Cancer immunotherapy, mathematical modeling and optimal control
From MaRDI portal
Publication:2219776
DOI10.1016/J.JTBI.2007.04.003zbMATH Open1455.92068OpenAlexW2081444498WikidataQ51913356 ScholiaQ51913356MaRDI QIDQ2219776FDOQ2219776
Authors: F. Castiglione, B. Piccoli 
Publication date: 21 January 2021
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2007.04.003
Recommendations
- Determination of the optimal therapeutic protocols in cancer immunotherapy
- Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics
- Optimal control of antigen-antibody interactions for cancer immunotherapy
- Optimal control applied to immunotherapy
- Optimal control in a model of dendritic cell transfection cancer immunotherapy
Medical applications (general) (92C50) Existence theories for optimal control problems involving ordinary differential equations (49J15)
Cites Work
- Optimization. Algorithms and consistent approximations
- Title not available (Why is that?)
- Modeling immunotherapy of the tumor -- immune interaction
- Optimal control in a model of dendritic cell transfection cancer immunotherapy
- A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
- Cancer Modelling and Simulation
- Hybrid Necessary Principle
- Immunotherapy: an optimal control theory approach
- Role of optimal control theory in cancer chemotherapy
- Optimal control applied to immunotherapy
Cited In (65)
- Optimal duration and dosage of BCG intravesical immunotherapy: A free final time optimal control approach
- Modeling of mouse experiments suggests that optimal anti-hormonal treatment for breast cancer is diet-dependent
- Numerical solutions and geometric attractors of a fractional model of the cancer-immune based on the Atangana-Baleanu-Caputo derivative and the reproducing kernel scheme
- The impact of radio-chemotherapy on tumour cells interaction with optimal control and sensitivity analysis
- THE EFFECT OF LENVATINIB AND PEMBROLIZUMAB ON THYROID CANCER REFRACTORY TO IODINE 131I SIMULATED BY MATHEMATICAL MODELING
- Treatment of bladder cancer using BCG immunotherapy: PDE modeling
- Optimal control in a model of dendritic cell transfection cancer immunotherapy
- PDE modeling of bladder cancer treatment using BCG immunotherapy
- Controlling IL-7 injections in HIV-infected patients
- Dendritic immunotherapy improvement for an optimal control murine model
- Equilibria and control of metabolic networks with enhancers and inhibitors
- A modified numerical method for bifurcations of fixed points of ODE systems with periodically pulsed inputs
- Metaheuristics and Pontryagin's minimum principle for optimal therapeutic protocols in cancer immunotherapy: a case study and methods comparison
- Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control
- Improved relaxations for the parametric solutions of ODEs using differential inequalities
- Optimal control homotopy perturbation method for cancer model
- A mathematical model of combined \textit{bacillus Calmette-Guerin} (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer
- Bacillus Calmette Guerin (BCG) immunotherapy for bladder cancer: a control and mathematical analysis
- Mathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response
- Modeling the effect of immunotherapies on human castration-resistant prostate cancer
- The combined effects of optimal control in cancer remission
- A mathematical model for the dynamics of cancer hepatocytes under therapeutic actions
- Optimal control problem for a general reaction-diffusion tumor-immune interaction system of mixed immunotherapy and chemotherapy
- Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine
- Optimal control of antigen-antibody interactions for cancer immunotherapy
- Effect of awareness programs and travel-blocking operations in the control of HIV/AIDS outbreaks: a multi-domains SIR model
- A mathematical model of tumour growth with Beddington-DeAngelis functional response: a case of cancer without disease
- Evolutionary game based control for biological systems with applications in drug delivery
- Determination of the optimal therapeutic protocols in cancer immunotherapy
- An optimal control approach to cancer treatment under immunological activity
- Mathematical and numerical analysis of a mathematical model of mixed immunotherapy and chemotherapy of cancer
- Data-driven optimal control of a SEIR model for COVID-19
- Optimal control for predicting customized drug dosage for superovulation stage of \textit{in vitro} fertilization
- Analysis of tumour-immune evasion with chemo-immuno therapeutic treatment with quadratic optimal control
- Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer
- T cell therapy against cancer: a predictive diffuse-interface mathematical model informed by pre-clinical studies
- OPTIMAL TREATMENT STRATEGIES USING DENDRITIC CELL VACCINATION FOR A TUMOR MODEL WITH PARAMETER IDENTIFIABILITY
- A nonlinear mathematical model of cell-mediated immune response for tumor phenotypic heterogeneity
- Spatial avascular growth of tumor in a homogeneous environment
- Bifurcation analysis of the cancer virotherapy system with time delay and diffusion
- A time delay model of tumour-immune system interactions: global dynamics, parameter estimation, sensitivity analysis
- A strategy of optimal efficacy of T11 target structure in the treatment of brain tumor
- A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
- A mathematical model of cancer treatment by immunotherapy
- Optimal CAR T-cell immunotherapy strategies for a leukemia treatment model
- Modeling pancreatic cancer dynamics with immunotherapy
- Personalized medicine for in vitro fertilization procedure using modeling and optimal control
- Bifurcation analysis of a delayed mathematical model for tumor growth
- Stability analysis of a mathematical model for glioma-immune interaction under optimal therapy
- Modelling pulsed immunotherapy of tumour-immune interaction
- Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approach
- Optimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approach
- Cost-effectiveness analysis of optimal strategy for tumor treatment
- An agent-based modeling framework linking inflammation and cancer using evolutionary principles: description of a generative hierarchy for the hallmarks of cancer and developing a bridge between mechanism and epidemiological data
- Global stability analysis and optimal control therapy of blood cell production process (hematopoiesis) in acute myeloid leukemia
- Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer
- Investigating of an immune system-cancer mathematical model with Mittag-Leffler kernel
- Mathematical models for immunology: current state of the art and future research directions
- Fractional order model of immune cells influenced by cancer cells
- Practically scheduling hormone therapy for prostate cancer using a mathematical model
- Maximization of viability time in a mathematical model of cancer therapy
- Bounding the dynamics of a chaotic-cancer mathematical model
- Optimal control of acute myeloid leukaemia
- Dynamics of fractional-order delay differential model for tumor-immune system
- Implementation of fractional optimal control problems in real-world applications
This page was built for publication: Cancer immunotherapy, mathematical modeling and optimal control
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2219776)
